Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Frazier Life Sciences Management, L.P. (CIK 1892134) reported $3.89B across 38 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: MIRM ($709.4M, 18.25%), NAMS ($542.4M, 13.96%), ERAS ($399.2M, 10.27%), BBIO ($256.1M, 6.59%), ARQT ($232.6M, 5.99%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | MIRM | MIRUM PHARMACEUTICALS INC | $709.4M | 18.25% | 7.7M | Added |
| 2 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $542.4M | 13.96% | 16.9M | Hold |
| 3 | ERAS | ERASCA INC | $399.2M | 10.27% | 24.7M | Added |
| 4 | BBIO | BRIDGEBIO PHARMA INC | $256.1M | 6.59% | 3.4M | Trimmed |
| 5 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $232.6M | 5.99% | 9.9M | Hold |
| 6 | MBX | MBX BIOSCIENCES INC | $198.6M | 5.11% | 6.7M | Hold |
| 7 | PHAT | PHATHOM PHARMACEUTICALS INC | $138.5M | 3.56% | 12.5M | Hold |
| 8 | MAZE | MAZE THERAPEUTICS INC | $136.3M | 3.51% | 4.6M | Hold |
| 9 | KRYS | KRYSTAL BIOTECH INC | $124.3M | 3.20% | 481,307 | Trimmed |
| 10 | TRVI | TREVI THERAPEUTICS INC | $118.6M | 3.05% | 9.9M | Trimmed |
| 11 | PVLA | PALVELLA THERAPEUTICS INC NE | $110.0M | 2.83% | 882,400 | Added |
| 12 | KALV | KALVISTA PHARMACEUTICALS INC | $99.9M | 2.57% | 5.0M | Trimmed |
| 13 | IRON | DISC MEDICINE INC | $86.6M | 2.23% | 1.4M | Added |
| 14 | CYTK | CYTOKINETICS INC | $76.4M | 1.97% | 1.2M | Added |
| 15 | RVMD | REVOLUTION MEDICINES INC | $65.7M | 1.69% | 675,686 | Trimmed |
| 16 | DYN | DYNE THERAPEUTICS INC | $57.2M | 1.47% | 3.2M | Hold |
| 17 | SVRA | SAVARA INC | $53.1M | 1.37% | 9.7M | Trimmed |
| 18 | TARS | TARSUS PHARMACEUTICALS INC | $51.1M | 1.32% | 728,644 | Hold |
| 19 | VOR | VOR BIOPHARMA INC | $45.4M | 1.17% | 2.5M | Hold |
| 20 | AGIO | AGIOS PHARMACEUTICALS INC | $42.5M | 1.09% | 1.3M | Trimmed |
| 21 | BCRX | BIOCRYST PHARMACEUTICALS INC | $38.2M | 0.98% | 4.0M | New |
| 22 | ZLAB | ZAI LAB LTD | $35.8M | 0.92% | 1.9M | Hold |
| 23 | AURA | AURA BIOSCIENCES INC | $34.1M | 0.88% | 5.1M | Hold |
| 24 | ACAD | ACADIA PHARMACEUTICALS INC | $32.0M | 0.82% | 1.4M | Added |
| 25 | ASND | ASCENDIS PHARMA A/S | $30.5M | 0.78% | 133,333 | Hold |
Source: SEC Form 13F filings · as of 2026-03-31